ROBERT ANDREW BERMAN

CIK 1258360 · Chief Executive Officer · last filed 2025-12-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$372.6K

Companies

5

Total Filings

40

Lifetime Open-Market Net

$60.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NVNO Chief Executive Officer 22,236 $10.00 $222.4K $30.6K 4 2025-12-18
enVVeno Medical Corp (NVNOW) Delisted Chief Executive Officer 210,236 $0.01 $1.3K $40.1K 4 2022-06-28
enVVeno Medical Corp (HJLIW) Delisted Chief Executive Officer 3,736 $0.56 $2.1K $66.4K 7 2021-05-19
Anixa Biosciences Inc (ITUS) Delisted President & CEO 51,653 $38.4K 5 2017-06-05
ACTG COO, Gen'l Counsel, Secretary 32,100 $4.68 $150.2K -$114.9K 1 2007-02-09

Recent Filings · Page 3 of 4

40 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-07-09 Buy (P) +200 $760
2015-07-02 Buy (P) +1,100 $4.2K
2015-07-01 Buy (P) +1,712 $7.3K
2015-06-23 Buy (P) +80,000 $11.8K
2015-06-18 Buy (P) +130,000 $17.3K
2015-06-11 Buy (P) +25,000 $3.6K
2015-06-10 Buy (P) +20,000 $2.8K
2015-06-04 Buy (P) +20,000 $3.2K
2015-06-01 Buy (P) +30,000 $4.3K
2015-03-24 Buy (P) +100,000 $11.1K
Showing 2130 of 40
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.